论文信息 - A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol - 字舞流文

A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol

Ying Cheng | E. Li | Yanqiao Zhang | Yian-qiu Jiang | Ye Xu | Lifeng Sun | K. Ding | Jun Li | Wei-sheng Zhang | Xiaohong Wu | Z. Pan | Jiayi Li | Ying Yuan | Chengcheng Liu | Xiaobing Chen | Hanguang Hu | Yue Liu | Ming-zhi Fang | R. Lin | Junye Wang | Songnan Zhang | Ye Chen | Dong Xu | Jin-jie He | Y. Cui | Chengcheng Liu | Jin-jie He | Jin-jie He | Y. Cui | Jiayi Li | Jun Li